249 related articles for article (PubMed ID: 8032662)
1. Ontogenic increase in PGE2 and PGF2 alpha receptor density in brain microvessels of pigs.
Li DY; Varma DR; Chemtob S
Br J Pharmacol; 1994 May; 112(1):59-64. PubMed ID: 8032662
[TBL] [Abstract][Full Text] [Related]
2. Fewer PGE2 and PGF2 alpha receptors in brain synaptosomes of newborn than of adult pigs.
Li DY; Varma DR; Chatterjee TK; Fernandez H; Abran D; Chemtob S
J Pharmacol Exp Ther; 1993 Dec; 267(3):1292-7. PubMed ID: 8263792
[TBL] [Abstract][Full Text] [Related]
3. Characterization and ontogeny of PGE2 and PGF2 alpha receptors on the retinal vasculature of the pig.
Abran D; Li DY; Varma DR; Chemtob S
Prostaglandins; 1995; 50(5-6):253-67. PubMed ID: 8838237
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of prostaglandin synthesis in newborn pigs increases cerebral microvessel prostaglandin F2 alpha and prostaglandin E2 receptors, their second messengers and vasoconstrictor response to adult levels.
Li DY; Abran D; Peri KG; Varma DR; Chemtob S
J Pharmacol Exp Ther; 1996 Jul; 278(1):370-7. PubMed ID: 8764372
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cerebrovascular prostaglandin E2 (PGE2) and PGF2 alpha receptors and their functions during development.
Chemtob S; Li DY; Abran D; Peri KG; Varma DR
Semin Perinatol; 1996 Jun; 20(3):164-72. PubMed ID: 8870119
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of brain PGE2 and PGF2 alpha receptors and receptor-coupled second messengers by cyclooxygenase inhibition in newborn pigs.
Li DY; Varma DR; Chemtob S
J Pharmacol Exp Ther; 1995 Jan; 272(1):15-9. PubMed ID: 7815327
[TBL] [Abstract][Full Text] [Related]
7. Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development.
Abran D; Dumont I; Hardy P; Peri K; Li DY; Molotchnikoff S; Varma DR; Chemtob S
Circ Res; 1997 Apr; 80(4):463-72. PubMed ID: 9118476
[TBL] [Abstract][Full Text] [Related]
8. Key role for cyclooxygenase-2 in PGE2 and PGF2alpha receptor regulation and cerebral blood flow of the newborn.
Li DY; Hardy P; Abran D; Martinez-Bermudez AK; Guerguerian AM; Bhattacharya M; Almazan G; Menezes R; Peri KG; Varma DR; Chemtob S
Am J Physiol; 1997 Oct; 273(4):R1283-90. PubMed ID: 9362291
[TBL] [Abstract][Full Text] [Related]
9. Increases in retinovascular prostaglandin receptor functions by cyclooxygenase-1 and -2 inhibition.
Hardy P; Bhattacharya M; Abran D; Peri KG; Asselin P; Varma DR; Chemtob S
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1888-98. PubMed ID: 9727412
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 and F2 alpha binding sites in the bovine iris ciliary body.
Csukas S; Bhattacherjee P; Rhodes L; Paterson CA
Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2237-45. PubMed ID: 8389343
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin moieties that determine receptor binding specificity in the bovine corpus luteum.
Anderson LE; Schultz MK; Wiltbank MC
J Reprod Fertil; 1999 May; 116(1):133-41. PubMed ID: 10505064
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.
Sharif NA; Xu SX; Williams GW; Crider JY; Griffin BW; Davis TL
J Pharmacol Exp Ther; 1998 Aug; 286(2):1094-102. PubMed ID: 9694973
[TBL] [Abstract][Full Text] [Related]
13. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by interacting with prostanoid receptors of the EP3-subtype.
Spicuzza L; Giembycz MA; Barnes PJ; Belvisi MG
Br J Pharmacol; 1998 Mar; 123(6):1246-52. PubMed ID: 9559911
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
Lawrence RA; Jones RL
Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050
[TBL] [Abstract][Full Text] [Related]
17. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture.
de Brum-Fernandes AJ; Morisset S; Bkaily G; Patry C
Br J Pharmacol; 1996 Aug; 118(7):1597-604. PubMed ID: 8842420
[TBL] [Abstract][Full Text] [Related]
19. Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.
Sharif NA; Davis TL
J Pharm Pharmacol; 2002 Apr; 54(4):539-47. PubMed ID: 11999132
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
Kay LJ; Yeo WW; Peachell PT
Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
